HK Stock Market Move | Zai Lab (09688) rose more than 5%, ZL-1310 received orphan drug designation from the US FDA.
ZaiDing Medical (09688) rose by more than 5%, as of the time of writing, it increased by 4.75%, trading at HKD 20.95, with a turnover of HKD 6.3193 million.
ZAI LAB (09688) rose over 5%, at the time of writing, up 4.75% to 20.95 Hong Kong dollars, with a turnover of 6.3193 million Hong Kong dollars.
On the news front, on January 23, ZAI LAB announced that the U.S. Food and Drug Administration (FDA) has granted ZL-1310 orphan drug designation (ODD). ZL-1310 is a highly active DLL3 ADC with first-in-class potential for the treatment of small cell lung cancer (SCLC). ZL-1310 will be eligible for certain development incentives, including waiver of the Prescription Drug User Fee Act (PDUFA) registration fee, tax credits for corresponding clinical studies, and a potential seven-year market exclusivity in the United States upon product approval.
RECOMMEND
General Administration of Customs: China's goods trade imports and exports increased by 2.4% year-on-year in the first 4 months.
09/05/2025
Key details are yet to be finalized. The market's response to the US-UK trade agreement has been lukewarm.
09/05/2025
Risk assets rebounded to boost the market, Bitcoin surged back above $100,000.
09/05/2025
